The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,060.00
Bid: 1,058.00
Ask: 1,060.00
Change: 24.00 (2.32%)
Spread: 2.00 (0.189%)
Open: 1,016.00
High: 1,080.00
Low: 1,004.00
Prev. Close: 1,036.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SAYE Option Scheme & PDMR Dealing

25 Nov 2022 16:22

RNS Number : 6817H
CVS Group plc
25 November 2022
 

 

 

25 November 2022

CVS Group plc

("CVS" or the "Company")

 

Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing

CVS Group plc (the "Company") announces that as part of its 2022/2023 Save As You Earn share scheme (the "SAYE Scheme"), which is open to all employees of the Group, the Executive Directors named below have elected to participate in the SAYE Scheme and have been granted SAYE Scheme options as follows:

 

Richard Fairman 380 SAYE scheme options

Robin Alfonso 403 SAYE scheme options

Ben Jacklin 403 SAYE scheme options

 

Eligible employees were invited to subscribe for options over the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price of 1,515 pence per share, representing a 20% discount to the average closing middle market price for the three dealing days prior to 1 November 2022, being the invitation date.

 

In response to accepted invitations, a total of 381,689 SAYE Scheme options over Ordinary Shares were granted on 25 November 2022, equating to 0.54% of the current issued ordinary share capital. Subject to the rules of the SAYE Scheme, these options will be capable of exercise from the maturity date on 1 January 2026.

 

The notification below, made in accordance with the requirements of UK MAR, provides further detail.

 

Contacts:

 

CVS Group plc via Camarco

Richard Fairman, CEO

Jenny Farrer, Group Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

 Toby Strong +44 (0)7789 151 644 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Fairman

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,515p

380

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

25 November 2022

f)

Place of the transaction

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robin Alfonso

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,515p

403

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

25 November 2022

f)

Place of the transaction

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ben Jacklin

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,515p

 

403

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

25 November 2022

f)

Place of the transaction

Off market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPGBGGUPPGQA
Date   Source Headline
26th Nov 20157:00 amRNSAnnual General Meeting Statement
2nd Nov 20153:50 pmRNSPosting of Annual Report and Notice of AGM
30th Oct 20159:42 amRNSChange of Registered Office
28th Oct 20152:58 pmRNSHolding(s) in Company
26th Oct 20154:59 pmRNSHolding(s) in Company
26th Oct 20157:00 amRNSAcquisition of Highcroft Pet Care
14th Oct 20159:14 amRNSHolding(s) in Company
12th Oct 20159:24 amRNSHolding(s) in Company
9th Oct 20151:57 pmRNSHolding(s) in Company
8th Oct 201511:21 amRNSHolding(s) in Company
7th Oct 20159:55 amRNSExercise of Options, TVR and Director Dealing
1st Oct 20157:00 amRNSAcquisition of Alnorthumbria Veterinary Practice
29th Sep 20157:00 amRNSPublication of Annual Report and Change of Website
25th Sep 20157:00 amRNSPreliminary Results
25th Aug 20159:06 amRNSHolding(s) in Company
27th Jul 20157:00 amRNSTrading Update
16th Jul 20154:33 pmRNSHolding(s) in Company
30th Jun 20157:00 amRNSTotal Voting Rights
15th Jun 20157:00 amRNSBlocklisting Interim Review
1st Jun 20157:00 amRNSTotal Voting Rights
28th May 201512:01 pmRNSHolding(s) in Company
6th May 20153:59 pmRNSHolding(s) in Company
30th Apr 20157:00 amRNSTotal Voting Rights
24th Apr 20153:56 pmRNSHolding(s) in Company
15th Apr 201510:59 amRNSHolding(s) in Company
10th Apr 20153:32 pmRNSHolding(s) in Company
9th Apr 20151:14 pmRNSDirector Dealing
7th Apr 201510:17 amRNSHolding(s) in Company
31st Mar 20157:00 amRNSTotal Voting Rights
30th Mar 20157:00 amRNSAcquisition of Your Vets and New Bank Facilities
20th Mar 20157:00 amRNSInterim Results
18th Mar 201511:54 amRNSExercise of Options and Total Voting Rights
13th Mar 20154:26 pmRNSHolding(s) in Company
10th Mar 201510:14 amRNSHolding(s) in Company
2nd Mar 201510:30 amRNSTotal Voting Rights
12th Feb 20152:13 pmRNSHolding(s) in Company
6th Feb 201511:15 amRNSExercise of Options and Total Voting Rights
30th Jan 20157:00 amRNSTotal Voting Rights
28th Jan 20152:12 pmRNSHolding(s) in Company
20th Jan 201511:01 amRNSNotification of Interim Results
6th Jan 201512:09 pmRNSDirector Dealing
6th Jan 20157:00 amRNSExercise of Options and Total Voting Rights
29th Dec 20147:00 amRNSExercise of Options and Total Voting Rights
9th Dec 20143:45 pmRNSBlock Admission
4th Dec 20143:25 pmRNSResult of AGM
4th Dec 20147:00 amRNSAGM Statement and ShareSave Scheme
3rd Dec 201412:50 pmRNSHolding(s) in Company
27th Nov 20143:24 pmRNSExercise of Options and Total Voting Rights
10th Nov 20149:42 amRNSHolding(s) in Company
6th Nov 20149:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.